Well. I guess you could probably pin some blame on publication bias for the massive misinvestment that went into the recent dementia meds that all failed at pha

Well. I guess you could probably pin some blame on publication bias for the massive misinvestment that went into the recent dementia meds that all failed at phase 3. Something made them get the science badly wrong. I was talking specifically in the context of evidence based medicine for regulatory decision making, which is the process that replaced blue envelopes full of money or throwing acedemic papers at an important politician whose relative had the disease that came before it.